Scilex Holding (SCLX) Goodwill & Intangibles (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Goodwill & Intangibles of $73.3 million for Q1 2026, down 1.31% year-over-year from $74.3 million in Q1 2025, and down 30.38% on a QoQ basis from $105.3 million in Q4 2025.

Scilex Holding (SCLX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Goodwill & Intangibles for 6 consecutive years, with $73.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 1.31% year-over-year to $73.3 million; the TTM figure through Mar 2026 stood at $73.3 million (down 1.31% YoY), while the FY2025 annual figure was $105.3 million, up 41.74% from the prior year.
  • Goodwill & Intangibles came in at $73.3 million for Q1 2026 at Scilex Holding, down from $105.3 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $105.3 million in Q4 2025, with the low at $5.0 million in Q1 2022.
  • Average Goodwill & Intangibles over 5 years is $53.3 million, with a median of $52.0 million recorded in 2023.
  • Across the five-year window, Goodwill & Intangibles jumped 1385.62% in 2023 and plunged 39.5% in 2025, its largest moves.
  • Year by year, Goodwill & Intangibles stood at $54.1 million in 2022, then surged by 37.29% to $74.3 million in 2023, then changed by 0.0% to $74.3 million in 2024, then soared by 41.74% to $105.3 million in 2025, then plunged by 30.38% to $73.3 million in 2026.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $73.3 million, $105.3 million, and $43.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 73.29 Mn
Dec 31, 2025 105.26 Mn
Sep 30, 2025 43.90 Mn
Jun 30, 2025 44.94 Mn
Mar 31, 2025 74.26 Mn
Dec 31, 2024 74.26 Mn
Sep 30, 2024 46.94 Mn
Jun 30, 2024 74.28 Mn
Mar 31, 2024 48.96 Mn
Dec 31, 2023 74.26 Mn
Sep 30, 2023 50.99 Mn
Jun 30, 2023 52.04 Mn
Mar 31, 2023 74.28 Mn
Dec 31, 2022 54.09 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 5.00 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 52.30 Mn